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VITREOUS CYTOKINE PROFILE AFTER PHACO-EMULSIFICATION AND 
 
POSTERIOR SEGMENT CHAMBER LENS PLACEMENT 
 
SHIMUL BEGUM 
ABSTRACT 	  
The purpose of this study was to quantify the effects of phacoemulsification and 
posterior segment chamber lens placement on vitreous inflammatory and neovascular 
growth factors. More specifically, the effect of immediately preceding cataract surgery 
was compared to a history of cataract surgery. This study involved a retrospective review 
and analysis of vitreous samples from a total of twenty seven patients separated into three 
groups. Group 1, seven patients who underwent a pars plana vitrectomy with macular 
surgery, group 2, fourteen patients who underwent a combined cataracts and pars plana 
vitrectomy procedure and group 3, six patients with a history of cataract surgery who 
underwent a pars plana vitrectomy. The twenty seven patients were picked from a pool of 
100 patients who all received pars plana vitrectomy at Beth Israel Deaconess Medical 
Center with surgeon Dr. Jorge Arroyo. Exclusion factors included active ocular 
pathologies such as vitreous hemorrhage and retinal detachment. Undiluted vitreous 
samples from each group were taken before beginning the pars plana vitrectomy. The 
vitreous samples were analyzed for concentrations of fourteen specific vitreous cytokines 
and neovascular growth factors including but not limited to TNF α and SCD40L. These 
fourteen cytokines and growth factors were chosen through a literature review on the 
post-surgery ocular inflammatory response. Statistical analysis was done on the average 
	  	   v 
means of the cytokine levels for each group using SPSS 20 for windows. A comparison 
of means analysis found no significant difference in the means of the fourteen cytokines 
for group 1 and group 2. A second comparison of means with a pooled control group of 
both group 1 and group 2 patients versus group 3 was also run.  In this analysis, only 
SCD40L or soluble CD40 ligand was shown to have a significant difference between 
groups.  SCD40L levels were significantly higher (significance level of .038) in group 3, 
the history of cataract group with a mean of (9.50±4.76) than in the control group with a 
mean of (5.50±3.35). The findings of this study indicate that the protein SCD40L may 
play an important role in mediating the inflammatory response seen post cataract surgery 
and may be useful as a target for novel therapies against the inflammatory response.  
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INTRODUCTION 
Statement of purpose  
A leading cause of preventable blindness in the elderly, age related cataract is 
increasing in incidence around the world. Cataract surgery is considered one of the safest 
procedures in ophthalmology and has also been steadily increasing in incidence across 
both sexes over the last few decades (Erie, 2013). Despite the safety and increasing 
occurrence of cataract surgery, it involves significant changes to the physical structure of 
the eye. These changes include alteration of the geometry of the intraocular chambers, 
decreased barrier function between the anterior and posterior segments of the eye and 
post-operative intraocular inflammation (American Academy of Ophthalmology Cataract 
and Anterior Segment Pane, 2011).  The purpose of this retrospective review is to 
quantify the effect of cataract surgery on both vitreous inflammatory cytokines and 
neovascular growth factors.  
 
 
 
Figure 1. Increase in Incidence of Cataract Surgery. (Age and sex adjusted 
rates of cataract surgery, Erie, (2013). Accessed 2/11/2015. Reproduced with 
permission from ( http://www.mayoclinic.org/medical-professionals/clinical  
updates/ophthalmology/incidence-cataract-surgery-continues-increase-steadily).  	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Cataract 
A cataract by definition is a clouding or loss of transparency due to opacification 
in the lens of the eye. The lens is responsible for both its refractive power and its role in 
focusing light on the retina. The lens can be found in the anterior of the eye, it is situated 
behind the iris and the cornea. The lens is biconvex and transparent. The transparency of 
the lens is due to a number of factors including the crystallins or proteins that make up 
the nucleus and cortex of the lens. A lack of vasculature within the lens also lends itself 
to transparency (Abdelkader, Alany, & Pierscionek, 2015).   
 
 
The Lens 
 
The single cuboidal epithelial layer of the lens is necessary for all metabolic 
activity within the lens. The epithelium is also involved in the production of UV filters 
that are necessary to protect the lens from potential damage from UV radiation (Bjerrum, 
Figure	  2:	  Normal	  Eye	  and	  Cataract	  Eye. A comparison between an eye with 
cataract and a normal eye. (2015). Accessed 2/05/2015.Reproduced with 
permission from (http://www.eyediseases.co/cataract-surgery-causes-dry-eye/)	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2015).  The lens is located within the lens capsule, the capsule itself is transparent and 
thin which allows for its many functions. The semi-elasticity of the capsule allows the 
lens within it to change shape according to changes in distance and or shape. The capsule 
also protects the lens from harmful biological molecules but allows entrance of necessary 
molecules such as glucose and amino acids (Abdelkader et al, 2015).  
 
 
 
 
 
 
 
 
There may be many different types of cataract. Although age related cataract is 
responsible for the majority of cataract cases around the world, the table below illustrates 
some other types of cataract.  
 
 
 
Figure	  3:	  The	  Lens.	  The components and positioning of the lens. The Eye 
Lens.  Karen Smith, (September, 8, 2004). Accessed 2/05/2015.  
Reproduced with permission from 
(http://www.thenakedscientists.com/HTML/articles/article/karensmithcolu
mn3.htm/.)	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Types of Cataract  
1.Age related Cataract  Age related cataracts account for the 
majority of cataract. This form of cataract 
will be the focus of this analysis.  
2. Secondary to Trauma/Other diseases   Cataract can also be secondary to 
instances of trauma and or other ocular 
diseases such as uveitis.  
3.Congenital Cataract   This is the rarest form of cataract and is 
present at birth.  
 
 
 
Age Related Cataract 
The natural lens goes through a multitude of changes over time which can lead to 
the production of an age related cataract. The lens nucleus grows with age and increases 
in both weight and thickness. The growth of the lens can prevent it from receiving the 
necessary nutrients from the epithelium. There is a decrease in protein turnover and the 
older proteins of the nucleus are then susceptible to processes like phosphorylation. The 
increase in post translational modifications and a buildup of chromophores and 
flurophores can then transform into a cataract. (Patel, Stelzner, Griffiths, Heersink, 2014). 
Below is a table summarizing morphological, biochemical and physical changes that take 
place during the aging of the lens and the creation of a cataract.  
 Table 1. Three Major Forms of Cataract. This table was 
made with information from (Bjerrum, 2015).  	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Types 
The cataract can be characterized by the position of its formation relative to the 
lens. The three major types of age related cataract are nuclear sclerotic, cortical and 
posterior subcapsular. These three types of cataract can differ in symptoms and 
presentation but they may also overlap in their occurrence (Patel, Stelzner, Griffiths, 
Heersink, 2014). Nuclear sclerotic cataract is slow forming and involves hardening of the 
center of the lens. Cortical cataract occurs when the fibers surrounding the nucleus 
become opaque. Posterior subcapsular cataract is caused by opacity in cortical layer 
under the capsule (Patel, Stelzner, Griffiths, Heersink, 2014). Below are the major 
designations of age related cataract and their physical presentations in the eye.  
Table 2. Major Age-Related Changes of the Lens. Reproduced with 
permission from ( Abdelkader et al, 2015).  	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Figure 4. The Three Major Designations of 
Cataract. Types of Cataract (2014) .Accessed 
February,05,2015. Reproduced with permission from 
(http://www.myeyes.com/cataracts/all-about-
cataracts.shtml)	  
 
 
 
Figure 5. The Three Major Types of Cataract in Eye. 
The Three Types of Cataracts, Hoopesvision (August, 
15, 2013). Accessed February, 6, 2015. Reproduced with 
permission from 
(http://www.hoopesvision.com/public/blog/news-about-
lasik-in-utah-at-hoopes-vision/types-of-cataracts/) 
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Symptoms 
There are a series of general symptoms and changes that occur with the 
presentation of any cataract. Some general symptoms include blurry vision, glare, and 
difficulty in discerning color, double vision or loss of contrast sensitivity (Patel, Stelzner, 
Griffiths, Heersink, 2014). Below are some of the specific symptoms associated with 
each type of cataract.  
 
Type of Cataract  Symptoms  
Nuclear Sclerotic  Nearsightedness/worsening of distance 
vision 
Myopia  
Poor night vision 
Glare  
Decreased ability to discern color 
Cortical  Glare 
Decreased distance and near vision  
Decreased contrast sensitivity  
Posterior Subcapsular  Worsening of near vision  
Glare  
Diminishing night vision  
Usually occurs in younger patients  
Faster progression than Nuclear Sclerotic  	  
Overall, cataract usually results in declining vision that cannot be corrected with 
glasses and must be removed for the improvement of vision. Below is a depiction of what 
vision might be for a patient suffering from cataract.  
 
Figure	  6.	  Vision	  Through	  
Cataract.	  (2015)	  Accessed	  February,	  6,	  2015.	  Reproduced	  with	  permission	  from	  (http://peposevision.com/cataracts/)	  	  
Table	  3.	  Common	  symptoms	  for	  each	  type	  of	  cataract.	  Made	  with	  information	  from	  (Patel, Stelzner, Griffiths, 
Heersink, 2014). 	  
	  8	  
 
 
 
 
 
 
Table 4: Risk Factors Associated with Increased Risk of Cataracts, 
American Academy of Ophthalmology Cataract and Anterior Segment 
Panel. Preferred Practice Pattern Guidelines. Cataract in the Adult Eye. San 
Francisco, California:  Reproduced with permission from American 
Academy of Ophthalmology; 2011  	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Risk Factors 
  
There have been some established and long standing risk factors for the 
development of cataract. These risk factors include diabetes, previous ocular surgery, 
smoking, and the use of steroids. Each specific type of cataract has its own unique set of 
risk factors and this can be seen in the preceding table from the American Academy of 
Ophthalmology Cataract and Anterior Segment Panel, 2011. 
Diagnosis  
 The major goal in diagnosing a cataract is determining if there is a visually 
significant change in the lens and whether this is the cause of the decreased vision. If the 
cataract is in fact the cause of the vision loss, further steps must be taken to determine if 
surgical removal of the cataract is advisable. The American Academy of Ophthalmology 
recommends that diagnosis includes the following steps. Initially there must be an 
evaluation of the level of visual impairment reported by the patient. Visual impairment 
can be measured with existing tests of visual acuity, glare, and contrast sensitivity. The 
academy recommends the Snellen visual acuity test in addition to measures of visual 
functional status like the Activities of Daily Vision Scale (American Academy of 
Ophthalmology Panel, 2011). 
 In addition to the visual impairment exam, the patient must have a full 
ophthalmic evaluation, which includes but is not limited to patient medical history, 
external examination of the eye, dilated examination of the posterior eye and assessment 
of the patient’s mental and physical status. In addition to these two examinations, there 
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are additional ophthalmic testing that may be done, including optical coherence 
tomography and B-Scan ultrasonography (American Academy of Ophthalmology Panel, 
2011).  
Treatment Options  
Nonsurgical  
At present, the best treatment option for cataract is surgery. There are no 
pharmacological treatments that prevent the formation of cataract or remove existing 
cataract. Patients are advised to lower their risk of cataract by decreasing exposure to risk 
factors such as smoking and steroid use (American Academy of Ophthalmology Panel, 
2011). Despite the lack of existing non surgical treatments, there are some potential 
treatments under development; two worth noting are the use of Aspirin and exogenous 
antioxidants. 
1. Aspirin and aspirin like drugs have been effective in delaying cataract 
formation in animal models; however the mechanism is still unclear. This drug therapy 
would require relatively large doses for a considerable amount of time (4 to 6 months) to 
have the desired effect and the systemic side effects of such usage currently outweigh the 
benefit (Abdelkader et al, 2015).  
2. Exogenous antioxidants such as N-acetylcysteine have been shown in certain 
instances to aid in the prevention and treatment of cataract. However, there have been 
mixed findings about the usefulness of oral antioxidant supplements. Supplements may 
not be sufficient enough to accrue the level of antioxidants needed for effect. More recent 
research is focused on improving the delivery of useful biological molecules to the 
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anterior segment of the eye directly thereby circumventing issues with unrealistic or 
harmful oral dosages (Abdelkader et al, 2015). 
Cataract Surgery  
Indication for cataract surgery is primarily decreased visual function and a 
likelihood of improved functionality post surgery. Contraindications for cataract surgery 
include likelihood that the vision will not improve post surgery, an underlying medical 
condition that prevents the patient from undergoing surgery and a decreased possibility of  
appropriate post-operative care (American Academy of Ophthalmology Panel, 2011). 
There are three different techniques currently in use for cataract surgery, 
phacoemulsification, extracapsular cataract surgery and intracapsular cataract surgery 
(Patel et al, 2014). The secondary goal of cataract surgery is to replace the removed lens 
with an intraocular lens. The lens is placed in during the surgery, the location and type of 
IOL inserted may differ from patient to patient (Patel et al, 2014).  
Extracapsular Cataract Extraction Surgery (ECCE): The entire nucleus of the 
cataract is removed from the eye in one piece. This option requires a larger incision than 
phacoemulsification and is often used for advanced cataracts.  Subsequent technique 
developed after ICCE that allows placement of IOL into the capsular bag. 
Intracapsular Cataract Extraction Surgery (ICCE): Very rare, involves the removal 
of both the lens and the capsule and the subsequent placement of new lens in front of the 
iris. Early surgery technique used before artificial lenses were invented and routinely 
placed in the eye.  
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Phacoemulsification: The most popular method of cataract extraction, ultrasound energy 
is used to break up the cataract and then the fragments are aspirated. This is traditionally 
done by making an incision but laser options are now also available. A new lens is then 
inserted. This is ECCE with use of phacofragmentation to remove the nucleus. 
 
 
 
 
Complications of Cataract Surgery/Phacoemulsification 
Cataract surgery is a fairly safe procedure and the risk of complete vision loss 
post-surgery is very low. Noted post surgical complications include endophthalmitis, 
cystoid macular edema, suprachoroidal hemorrhage, retinal detachment, toxic anterior 
segment syndrome, corneal edema, and IOL dislocation and general post operative 
Figure 7. Cataract Extraction Methods. This figure shows two 
available methods of phacoemulsification, the most popular 
method of cataract extraction. Accessed February, 07, 2015. 
Reproduced with permission from( http://imgkid.com/types-­‐of-­‐cataract.shtml)	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intraocular inflammation. (American Academy of Ophthalmology Panel, 2011). Some 
peri-operative complications include, lens capsular tear, loss of vitreous and loss of 
nuclear material in the vitreous (Abdelkader et al, 2015). The table below shows statistics 
for some of the complications mentioned above.  
 
Table 5. Complication Rates from Selected Studies of Cataract Surgery.  
Reproduced with permission from American Academy of Ophthalmology 
Panel, 2011.	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Intraocular Inflammatory Response 
The intraocular inflammatory response post cataract surgery can be of special 
concern because of its role in the formation of other complications. The inflammatory 
cytokine response has been shown post-cataract surgery in prior cytokine studies. 
Previous research has also cited inflammatory cytokines as key players in the 
development of specific ocular complications. A retrospective research study in Denmark 
found that the risk of pseudophakic retinal detachments increased by a factor of 4.2 post 
cataract surgery. This increase in risk was attributed to induced changes in the vitreous 
post cataract surgery and rotational changes in the vitreous base (Bjerrum, 2015).  
Fluctuations in the levels of inflammatory and angiogenic cytokines have been associated 
with the occurrence of retinal ischemia and recurrent macular edema (Jung, Kim, Sohn, 
and Yang, 2014).   
The levels of various cytokines including VEGF, IL-6, and MCP-1 were found to 
be correlated with vascular permeability in the retina and the occurrence of macular 
edema (Noma, Mimura, and Eguchi, 2013).  The inflammatory response can also have 
adverse effects on underlying health conditions including diabetic retinopathy and 
maculopathy (Yukki et al, 2001). The inflammatory response itself may be a result of 
specific ocular changes that take place during cataract surgery, including micro-trauma to 
ocular structure, changes in intraocular pressure, disruptions of the blood barrier and  a 
general immune response (Calvano, Lin, and Lowry, 2000). The inflammatory response 
itself is a fairly complex and orchestrated by a large web of vitreous cytokines and 
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neovascular growth factors. Understanding the specific changes in these factors may lend 
itself to mediating the inflammatory response.  
Cytokines 
In order to understand the inflammatory response, it is important to examine the 
cytokines that make up the response. Though similar to hormones in their role as 
signaling molecules, cytokines are glycoproteins or polypeptides that are produced either 
by immune cells or by cells at the site of an injury (Calvano, Lin, and Lowry, 2000). 
Cytokines are not stored in the body but produced as their actions are required. Thus, 
cytokines are released by the cells that make them and then use paracrine or autocrine 
mechanisms in order to fulfill their respective functions. Cytokines often play an 
important role in the differentiation, proliferation and survival of immune cells. In 
addition to immune cells, cytokines can also help regulate the activity of other cytokines. 
The co-regulation of cytokines provides an alternative method of mediating the 
inflammatory response. It is the over expression of cytokine activity that  leads to a 
pronounced or elongated inflammatory response (Calvano, Lin, and Lowry, 2000). 
Cytokines can bind to specific receptors within the cell that then activate regulatory 
pathways. These regulatory pathways are often downstream gene transcription signaling 
pathways (Calvano et al, 2000). More specifically, most inflammatory cytokines act by 
binding to a cognate receptor and activating a class of kinases called Janus (JAK). The 
cytokines also activate a set of transcription factors called signal transducers and 
activators of transcription (STAT) (Yu et al, 2011).  
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1) Cytokine binds its receptor. 
2) JAKS associated with the receptor transphorylate each other and are activated. 
3) A phosphotyrosine docking site is produced  
4) The phosphotyrosine docking site recruits and activates specific STAT proteins. 
5) Activated STAT’s enter the nucleus.  
6) Once in the nucleus, the activated STATs bind to specific DNA sequences and 
activate gene expression  
 
 
 
 
 
Figure 8. The mechanism of cytokine action. Action via JAK and STAT in 
the nucleus. Ibanez,Alsina, and Santos, 2013. Accessed February, 08,2015, 
reproduced with permission from  http://www.actasdermo.org/en/tofacitinib-
and-other-kinase inhibitors/articulo/90199756/?pubmed=true.  	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There are very many cytokines and growth factors involved with the 
inflammatory response. Previous studies on the inflammatory response and cataract 
surgery were utilized in order to shorten the list of cytokines and growth factors 
examined in this study. Below are some of the most pertinent and well cited cytokines of 
the inflammatory response. 
1) TNF or Tumor Necrosis Factor: One of the earliest mediators of the host 
response. TNF is made by monocytes, macrophages and T cells. It has a very 
short half life of about twenty minute. TNF can cause both metabolic and 
hemodynamic changes. It is known to activate coagulation and promote release of  
adhesion factors and platelet activating factor (Calvano et al, 2000). 
2) Interleukin 6 or (IL-6):  A critical mediator of inflammation produced by TNF 
and Interleukin . Can be produced by most cells and tissues of the body. 
Detectable levels of Il-6 can be produced in the body in about an hour (Calvano et 
al, 2000). The total amount of Il-6 produced can be correlated to the amount of 
tissue or cell damage in the body. This molecule may have a pro or anti 
inflammatory role, it is indirectly responsible for the production of other 
inflammatory cytokines. It most notably activates neutrophils and delays their 
destruction (Chen, Lin, Liu, Geng, Xi, and Zhong, 2014). Elevated levels of IL-6 
in the aqueous humor were correlated with impairment of the blood aqueous 
barrier function. Il-6 has been shown to increase vascular permeability and 
angiogenesis via VEGF (Jung et al, 2014).  
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3) Interleukin 8 (IL-8):  Strong chemoattractant that activates neutrophils and T-
lymphocytes. The expression and action of Il-8 is often connected to those of Il-6.  
Il8 has been known to promote both angiogenesis and tumor metastasis. Il8 has 
also been associated with the development of retinal ischemia (Jung  et al, 2014).  
4) GM-CSF (Granulocyte macrophage colony- stimulating factor):  Glycoprotein 
released by a number of immune cells including macrophages, T-cells, and Mast 
cells. Plays a role in delaying apoptosis of macrophages and neutrophils. Acts in 
wound healing and promoting the recruitment of other leukocytes (Calvano et al, 
2000). 
5) PDGF (Platelet derived growth factor): Growth factor which plays an important 
role in angiogenesis. Potent mitogen and chemoattractant for retinal pigmentary 
epithelium and it also promotes organogenesis and wound healing (Jung,2014). 
6) VEGF (Vascular endothelial growth factor): A signaling protein that promotes 
angiogenesis, necessary for production of new blood vessels after injury. Also 
important for vasculogenesis (Jung, 2014). VEGF is the key factor mediating the 
response to hypoxia in the retina (Noma, Mimura, and Eguchi, 2013).  
7) SCF (Stem Cell Factor): A cytokine which can act as a soluble and 
transmembrane protein. SCF binds the c-Kit receptor and plays a role in 
hematopoiesis and mast cell activity. Mast cells contain the c-kit receptor and 
SCF is able to promote and enhance mast cell activity by binding to c-kit (Yee, 
Paek, and Besmer, 1994).  
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8) SCD40L (Soluble CD40 ligand): This ligand is often found within platelet 
granules. It binds to the CD40, a receptor specific to endothelial cells which then 
leads to downstream release of other inflammatory molecules. SCD40L also plays 
a role in activating the coagulation pathway (Davidson et al, 2012). 
9) HbEGF (Heparin binding EGF like growth factor): A growth factor made by 
monocytes and macrophages. HbEGF can bind to the EGF receptor thereby 
affecting cell to cell signaling. The activity of HbEGF is prominent in the process 
of wound healing and angiogenesis via migration of fibroblasts and keratinocytes 
(Ushiro et al, 1996). 
10) PAI1 (Plasminogen activator inhibitor): a protein inhibitor of TPA (tissue 
plasminogen activator).Present predominantly in the endothelium and inhibits 
fibrinolysis. PAI has been associated with fibrosis in certain inflammatory 
conditions (Providence, Kutz, Coico and Higgins, 2000).  
11) HGF (Hepatocyte Growth Factor): A growth factor that acts on endothelial and 
epithelial cells. HGF is important for cell motility and is an anti inflammatory 
factor. HGF has been shown to disrupt pro inflammatory signaling in certain 
molecules via its autocrine and paracrine effects (Molnarfi et al, 2014). 
12) PECAM1 (Platelet Endothelial Cell Adhesion Molecule): A protein localized to 
the surface of many immunocytes including monocytes, neutrophils and platelets. 
PECAM1 plays an important role in maintaining junctions between endothelial 
cells allowing it to affect the strength of the endothelial cell barriers (Privratsky 
and Newman, 2014).  
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13) SFASL (Soluble FAS Ligand): A transmembrane protein which aids in the 
activation of apoptosis. SFASL is critical for regulation of the immune system, it 
plays an important role in t-cell activation and homeostasis (Fulda, Strauss, Meyer 
and Debatin, 2000).  
14) Angiopoietin 2: A vascular growth factor necessary for angiogenesis. 
Angiopoietin 2 has also been shown to play a significant role in inflammatory 
signaling pathways. Higher than normal levels of Angiopoietin 2 have been found 
in inflammatory conditions (Scholz, Plate, and Reiss, 2015).  
Pars Plana Vitrectomy (PPV)  
The purpose of a pars plana vitrectomy is to remove vitreous gel from the eye. 
While earlier forms of vitrectomy were performed with larger gauge instruments, the 
clinical use of smaller gauge instruments (27, 25, and 23) has increased substantially in 
the last decade.  Small gauge pars plana vitrectomy allows for controlled and closed 
access to the posterior portion of the eye. Pars plana vitrectomy was initially only utilized 
to clear the vitreous of opacities but has now been adapted for multiple uses. A general 
indication for the vitrectomy involves the presence of foreign materials or blood in the 
vitreous which causes distorted or reduced vision (Kozak et al, 2015).   
Indications for PPV 
1. Macular hole  
2. Vitreomacular Traction  
3. Refractory macular edema  
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4. Vitreous hemorrhage  
5. Retinal Detachment  
6. Floaters/ foreign material  
7. Dislocated IOL  
8. Epiretinal membrane  
PPV Procedure 
1. Sterile procedure with providone and iodine to prepare the eye.  
2. Measurements are made for the sclerotomy location  
3. Three different incisions are made in the eye via the pars plana located behind the 
iris but in front of the retina.  
4. The light pipe is a microscopic high intensity fiberoptic light used in the eye. 
5. The vitrector or vitreous cutter is introduced through the pars plana and used to 
cut and aspirate the vitreous in a controlled manner that reduces traction and 
maintains intraocular pressure.  
6. The infusion port is also inserted and used to replace the removed vitreous with a 
saline solution.  
7. Antibiotic eye drops and anti-inflammatory eye drops are prescribed post- surgery to help 
prevent complications.  
This procedure for pars plana vitrectomy was adapted from “Small Gauge Pars Plana 
Vitrectomy” by Trikha, Beharry, and Telander (2012).  
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Surgical Complications 
There are a few complications associated with a pars plana vitrectomy. The table 
below summarizes the possible complications during and after a pars plana vitrectomy. 
Some complications that can occur during the procedure include hypotony (an intraocular 
pressure lower than 5mm hg), dislocation of the inserted cannula and breakage of the 
surgical instrument in the eye. Complications post-surgery include hypotony, 
endophthalmitis (intraocular inflammatory condition) and retinal detachment (Trikha et 
al, 2012).  
 
 
Figure 9: Pars Plana Vitrectomy, Roy D. Brod, “Diagram depicting a 
3-port closed system pars plana vitrectomy in an eye with a vitreous 
hemorrhage”.(2009).Accessed 02/10/2015. Reproduced with permission 
from (http://www.jlgh.org/Past-Issues/Volume-4---Issue-1/Surgery-for-
Diseases-of-the-Vitreous-and-Retina.aspx.) 	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METHODS 
Study Design 
In the pursuit of quantifying the effect of cataract surgery on vitreous 
inflammatory and neovascular growth factors, a retrospective review and analysis was 
performed. Approval for the review was obtained from the Human Studies Committee 
before any steps were taken. The raw data for this review was obtained from the vitreous 
samples of a hundred patients who required Pars Plana Vitrectomy and Macular Surgery 
with surgeon Dr. Jorge Arroyo. The samples were collected from November of 2010  
until August of 2012. All of the procedures were done at Beth Israel Deaconess Medical 
Center during this time period.  
There were numerous exclusion and inclusion factors for this analysis. Patients 
who experienced floaters were included in the study in addition to patients who had an 
epiretinal membrane. Patients with macular holes, both with or without cystoid macular 
edema were also included in the study. Patients with all other active ocular pathologies 
such as vitreous hemorrhage and retinal detachment were excluded. The exclusion and 
inclusion factors were guided by the past literature on each of the pathologies and their 
characteristic inflammatory changes. Based on these inclusion and exclusion criteria, a 
total of twenty seven patients were identified for the study.  
The general effect of cataract surgery on vitreous inflammatory and growth 
factors was analyzed with respect to the timing of the cataract surgery. All of the patients 
in the study had undergone pars plana vitrectomy followed by macular surgery, however 
the incidence and timing of cataract surgery differed from patient to patient. The twenty 
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seven patients were broken up into three separate groups. The first group of patients 
contained patients with phakic eyes (eyes with their natural lens) who had undergone a 
pars plana vitrectomy with macular surgery only. This first group of patients was deemed 
the main control group for the study.  
The second group of patients included patients with phakic eyes who had 
undergone a combined procedure where cataract surgery was performed immediately 
prior to the pars plana vitrectomy with macular surgery. This second group of patients 
was considered the cataract surgery group. The third and last group was composed of 
pseudo-phakic patients with an artificial lens implant who had a history of cataract 
surgery. The third group of patients had variable time intervals between their cataract 
surgery and their pars plana vitrectomy with macular surgery. Each group had a different 
number of patients, the first group contained seven patients, the second group fourteen 
patients and the last group was the smallest with only six patients.  
 All of the patients in this study had their pars plana vitrectomy with macular 
surgery performed by the same vitreoretinal surgeon, Dr. Jorge G. Arroyo. All of the 
cataract surgery patients in group two or the cataract surgery group had their cataract 
extraction and intraocular lens implantation performed by the same anterior segment 
surgeon, Dr. Mark Kuperwaser. The cataract surgeries for the patients in the third group 
all differed in time, location and surgeon.  
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Cataract Surgery 
The cataract surgeries performed at the Beth Israel Deaconess center were 
performed first by the phacoemulsification technique using the Alcon Infiniti 
phacoemulsification unit (Alcon Laboratories Inc, Fort Worth, Texas, USA).  The 
procedure was done through a 2.6 mm clear-corneal incision followed by an intracapsular 
implantation of an Alcon SA60AT or SN60WF foldable acrylic posterior chamber 
intraocular lens (Alcon Laboratories Inc). A 10-0 nylon suture was used to ensure wound 
security prior to vitrectomy.  
Vitrectomy with Macular Surgery 
All of the vitrectomies included in this study were performed at Beth Israel 
Deaconess Medical Center. A standard 23-gauge, 3-port pars plana vitrectomy was 
performed using the Alcon Accurus vitrectomy unit (Alcon Laboratories Inc). The 
vitreous samples that were analyzed for this study were all taken prior to the Pars Plana 
Vitrectomy procedure. For the combined cataract and pars plana vitrectomy cases, the 
undiluted vitreous specimens were taken after the implantation of the intraocular lens and 
before the pars plana vitrectomy.  
An undiluted 1-2 cc vitreous specimen was obtained prior to infusion using a 
vitreous cutter. A 3 cc syringe on a three-way stopcock was used to manually aspirate the 
specimen. The sample was then centrifuged to remove confounding materials such as 
blood. The centrifuged samples were kept in a cold storage freezer at -80 degrees Celsius 
until they were sent for analysis. The samples were analyzed using Bio-Plex Pro Human 
Cancer Biomarker Assay and ELISA or Enzyme-Linked Immunosorbent Enzyme. Bio-­‐
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Plex	  Pro	  human	  cancer	  biomarker	  assays	  are	  a	  unique	  blend	  of	  magnetic	  bead–based	  assays	  designed	  to	  produce	  robust	  and	  reproducible	  measurements	  of	  thirty	  four	  biomarkers	  involved	  in	  processes	  such	  as	  angiogenesis,	  metastasis	  and	  inflammation.	  VEGF-­‐R3	  was	  the	  thirty	  fifth	  cytokine	  measured	  only	  via	  ELISA	  analysis.	  Results	  were	  reported	  in	  pictograms/ml	  except	  for	  the	  VEGF-­‐R3	  ELISA	  results,	  which	  were	  reported	  in	  nanograms/ml.	  The	  levels	  of	  the	  fourteen	  biomarkers	  specific	  to	  this	  study	  were	  taken	  from	  this	  analysis.	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  3 
Figure 10: Group design and sampling. This diagram illustrates the 
design of each group and the point of vitreous sample harvest in each 
group.  	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Statistical Analysis 
Statistical analyses were performed utilizing the SPSS software, specifically IBM 
SPSS Statistics version 20(IBM Corp., Chicago, Illinois, USA). The analysis of the 
vitreous samples was done for thirty five different vitreous cytokines and growth factors. 
This study only utilized data for fourteen out of the thirty five cytokines. These fourteen 
cytokines and growth factors were chosen according to significance and relevance to the 
inflammatory response as seen in previous research and publications. The fourteen 
cytokines and growth factors are, VEGF, Angiopoietin 2, GM-CSF, hB-EGF, HGF, IL6, 
IL8, PAI1, PDGF, PECAM1, SCD40L, SCF, sFASL, and TNF Alpha.  
For each of the fourteen cytokines two separate statistical analyses were done. 
First, the means of each cytokine level were compared between the patients in group one 
the control group and group two the cataract surgery group using an independent samples 
T-test. As will be presented later on in results, this first analysis determined no significant 
differences in cytokine levels post surgery for the control group and the cataract surgery 
group. These results were then used to the studies advantage by creating a second 
analysis where groups one and two were pooled together as one large control group. This 
new control group contained a total of twenty one patients, and once again the means of 
each cytokine level was compared between the samples of this larger control group and 
the samples from pseudophakic patients in group three. The results of these analyses were 
then interpreted in the context of existing literature and research on the topic.  
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Group	  1:	  Control	  
Group	  2:	  Cataract	  	  
T-­‐Test	  #1:	  Compare	  means	  of	  cytokine	  levels	  for	  each	  group	  via	  Independent	  samples	  T	  test.	  
Significant	  mean	  differences	  between	  groups	  	  
Analyze	  and	  interpret	  differences	  
No	  significance	  in	  comparison	  of	  means.	  
Data	  for	  groups	  1	  and	  2	  pooled	  into	  one	  large	  control	  group	  
T-­‐Test	  #	  2:	  Compare	  means	  of	  Cytokine	  levels	  via	  independent	  samples	  T-­‐test	  
Group	  3:	  Cataract	  then	  PPV	  group	  	  
Figure	  11.	  Statistical	  Analysis	  of	  Cytokine	  Levels	  Between	  the	  Three	  
Groups	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RESULTS 
	  
	  
 
 
Cytokine  Group 1:Control  
N=7 
Group 2: Cataract  
  N=14     Surgery 
Group 2 versus 
Group1   
 Mean  Standard 
Deviation  
Mean  Standard 
Deviation 
Fold 
Increase 
 Signifi 
 cance 
Angiopoietin 
2 
173.50 37.48 92.91 63.0 1, 0.54 .114 
GCSF 15.86 6.44 14.57 6.62 1,0.92 .677 
HbEGF* N/A N/A N/A N/A N/A N/A 
HGF 4004.71 3407.77 4971.64 2502.40 1, 1.24 .468 
IL6  36.57 58.32 14.07 21.42 1, 0.59 .357 
IL8 4.33 3.33 7.21 14.21 1, 1.67 .634 
PAI1 3117.86 2804.21 3548.36 4097.73 1,1.14 .806 
PDGF 19.43 7.09 22.93 5.04 1, 1.18 .206 
PECAM 1 344.57 73.68 360.43 76.48 1,1.05 .656 
SCD40L 5.60 3.36 5.45 3.5 1,0.97 .939 
SCF 37.14 14.82 43.57 11.79 1, 1.17 .292 
SFASL* N/A N/A N/A N/A N/A N/A 
TNF Alpha* N/A N/A N/A N/A N/A N/A 
VEGFA 19.83 14.30 45.85 87.29 1,2.31 .485 
 
*Very few patients in groups 1 and 2 had significant levels for the three starred 
cytokines; the levels fell below threshold and therefore could not be included in the 
analysis. Despite the lack of data for this analysis, groups 1 and 2 were still pooled for 
these cytokines and the second analysis against group 3 was still attempted for them. 
 
  
 
 
 
 
Table 6: Combined Results of Test One. First independent samples T-test 
between group 1 (control group) and group 2(Cataract surgery group) for all 
fourteen Cytokines.  	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Cytokine  Groups 1 and 2 
pooled N=21 
Group 3: Cataract 
and then PPV N=6 
Group (1+2) vs. Group 
3 
 Mean Standard 
Deviation 
Mean Standard  
Deviation 
Fold  
Increase 
Significance 
Angiopoietin 2 105.31 65.88 184.50 127.99 1, 1.75 .174 
GCSF 15 6.43 37.83 54.96 1, 2.52 .062 
HbEGF* n/a n/a n/a n/a n/a n/a 
HGF 4649.33 2787 4946 3428 1,1.06 .828 
IL6  21.57 37.90 67.83 121.51 1,3.14 .398 
IL8 6.35 11.95 5.50 2.34 1,0.87 .856 
PAI1 3404.86 3649.20 7257.50 7585.26 1,2.13 .276 
PDGF 21.76 5.87 24.00 5.66 1,1.10 .415 
PECAM 1 355.14 74.01 364.83 93.06 1,1.03 .791 
SCD40L 5.50 3.35 9.50 4.76 1,1.73 .038 
SCF 41.43 12.88 48.17 19.84 1,1.16 .326 
SFASL* n/a n/a n/a n/a n/a n/a 
TNF Alpha 1.75 .89 2.25 .5 1,1.29 .326 
VEGFA 37.63 72.74 84.00 111.34 1,2.23 .268 
 
 
 
 
 
*Very few patients in groups 1 and 2 had significant levels for the two starred cytokines; 
the levels fell below threshold and therefore could not be included in the analysis. Even 
pooled data from groups 1 and 2 did not provide enough data points for an accurate 
comparison of means against group 3. Note however that TNF alpha which did not have 
enough data points for the first comparison did when groups 1 and 2 were pooled have 
enough for the second comparison against group 3.  
 
 
 
 
 
 
 
Table 7. Combined Results of  Test 2. Independent samples T-test between 
group 1 and (control group) group 2(Cataract surgery group) pooled versus 
Group 3 (cataract and then PPV group) for all fourteen Cytokines. 	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Figure 12: Average fold increase of vitreous cytokines. Comparison of 
patients with a history of cataract surgery (Group3) compared to control group 
(Group 1+2). An arrow demarcates significantly elevated vitreous cytokines in 
patients with a history of cataract surgery (group3) compared to the control 
pool.  	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SPSS Results for SCD40L 
 
1. Comparison of means between groups 1 and 2(SPSS Output) 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
V4 
1 5 5.60 3.362 1.503 
2 11 5.45 3.503 1.056 
 
 
 
2. Comparison of means between groups (1+2) and group 3(SPSS Output) 
Group Statistics 
 Group N Mean Std. Deviation Std. Error Mean 
V4 
1 16 5.50 3.347 .837 
3 6 9.50 4.764 1.945 
 
 
	  
 
Table	  8:	  SCD40L	  Run	  1,Group	  Statistics	  	   Table	  9:	  
SCD40L	  Run	  
1,	  T-­‐test	  
Table	  10:	  SCD40L	  Run	  2,	  Group	  Statistics	  	  
Table	  11.SCD40L	  Run	  2,	  T-­‐test	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DISCUSSION 	  
The first analysis done for each of the cytokines was a comparison of means test 
between group one, the initial control group and group two, the cataract surgery group. 
This analysis was done using SPSS 20 and the output for all fourteen cytokines can be 
found in table 6 in the results section. An example of a raw SPSS output table can be seen 
in table 9 of the results section, this table is the output for SCD40L. In interpreting the 
table, the first thing to consider is the result of the Levene’s test for equality of variances. 
This test checks that the variances for two different groups pulled from the same 
population are equal. The result of Levene’s test determines which significance value to 
consider for the two tailed t-test for equality of means.  
Revisiting table 6 illustrates that although there seem to be obvious differences in 
the average means between the two groups, there are no significant differences in means 
for any of the cytokines. This can be interpreted as there being no significant difference 
in the levels of the thirty five vitreous inflammatory cytokines and vascular growth 
factors in patients who only underwent a pars plana vitrectomy versus patients who 
received a combined cataract and pars plana vitrectomy. An analogous analysis between 
group 1 and group 3 yielded mixed results and therefore required further analysis. The 
lack of significant difference between groups 1 and 2 was used to the advantage of the 
study by pooling the patients in the two groups. This larger group was utilized as a 
control group for our second comparison of means test against group 3 ( history of 
cataract and then pars plana vitrectomy group). It is also evident from table 6, that three 
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of the cytokines do not appear to have output data. SFASL, TNF alpha and HbEGF did 
not have enough data points for an accurate analysis. The concentrations for these 
cytokines were found to be lower than the lowest threshold for analysis in many of the 
patient from group 1 and group 2 thereby leaving very few usable data points.  
The second analysis was a comparison of means test done via SPSS 20 between 
the large control group of pooled group 1 plus group 2 patients and group 3, the history of 
cataract surgery and then pars plana vitrectomy group. This pooling was justified by the 
results from the first comparison of means test which revealed no significant differences 
between group 1 and 2. This second analysis was once again done for all fourteen 
cytokines and the results have been summarized in Table 7 of the results section. The 
comparison of means between this group yielded similar results to the first analysis such 
that, there do not appear to be significant differences in means between the large control 
group and group 3 for most of the cytokines. As with the first analysis, it can be seen that 
cytokines, HbEGF and SFASL did not have enough data points for adequate testing. TNF 
alpha however was adequately tested in analysis two because the pooling of groups 1 and 
2 for TNF alpha was able to sufficiently increase the number of data points.  
 The only cytokine that is shown to have a significant difference in means for the 
control group versus group 3 is SCD40L. Average SCD40L levels were significantly 
higher (significance level of .038) in group 3, the history of cataract group with a mean of 
(9.50±4.76) than in the control group with a mean of (5.50±3.35). The raw SPSS output 
charts for each analysis of SCD40L can be found in tables 8 through 11. Figure 12 is a 
plot of the cytokines and their fold increase between the control group and group 3. There 
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is a 1.73 fold increase in the mean level of SCD40L in group 3 compared to the mean 
level of SCD40L in the control group.  
The findings in regards to SCD40L levels in patients with a history of cataract 
surgery are well supported by literature and not surprising. However, the lack of 
significant SCD40L levels in the samples from group 2 is interesting. The vitreous 
samples for this group were taken immediately after the cataract surgery and before the 
subsequent pars plana vitrectomy whereas the vitreous samples for the members of group 
3 were taken many months to years after the cataract surgery. Time seems to be a 
significant factor underlying the differences in cytokine levels post cataract surgery. The 
patients in group 2 may not have had enough time immediately after the cataract surgery 
to build up a significant inflammatory response, thus showing insignificant differences in 
cytokine levels.  
 The role of SCD40L in retinal inflammation as well as other neurovascular 
conditions has been previously well documented.  SCD40L is found within platelet 
granules and platelet activation leads to the release of SCD40L. Platelets themselves play 
an important role in physiological inflammation and endothelial vascular repair (Damien 
et al, 2015). CD40 is the receptor for SCD40L and serves as the mechanism for its effects 
in the body.  
“CD40 is a member of the TNFR super-family that regulates many aspects of 
cellular and humor immunity. CD40 is a regulator of inflammatory disorder, and studies 
using non ocular cells revealed that -the CD40 induces NOS2, and COX-2, triggers 
chemokine production (MCP-1, IL-8, and MIP-2) and up regulates ICAM-1.”(Portillo et 
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al, 2008, pg.8719). Experiments involving mouse models have demonstrated that CD40 
knock -out mice with simulated retinal ischemia did not develop inflammation. Portillo et 
al, 2008 found that muller cells express CD40 receptors which then cause adhesion 
molecule up regulation as a possible mechanism of inflammation in the retina.  
The recruitment of leukocytes by the CD40 receptor can also play a role in the 
resulting inflammation. “CD40L on platelets induces endothelial cells to secrete 
chemokines and to express adhesion molecules, thereby generating signals for the 
recruitment and extravasation of leukocytes at the site of injury” (Henn et al, 1998, pg 
591). Leukocytes have been linked to the breakdown of the blood-retinal barrier, which 
can cause complications such as macular edema. Blocking the CD40 receptor may impair 
leukocyte activation and thereby prevent this branch of inflammation (Portillo et al, 
2008).  
Possible SCD40L Related Interventions 
The result of this analysis in regards to elevated levels of SCD40L post cataract 
surgery are supported by the literature, these findings may be utilized to prevent an ocular 
inflammatory response. The following are some possible interventions for a SCD40L 
mediated inflammatory response. One possible intervention for the inflammatory 
response exists in the form of inhibiting platelet activation. Platelet activation is 
necessary for the elevation in SCD40L levels, inhibiting platelet activation may also 
inhibit the downstream actions of SCD40L. Several existing drugs including Abciximab, 
Eptifibatide, and Tirofiban target glycoprotein IIb/IIIa, an integrin complex necessary for 
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platelet activation. These drugs may also potentially be used to mediate the SCD40L 
related inflammatory response.  
Portillo et al, 2008 acknowledge the importance of the CD40 receptor in the role 
of SCD40L as an inflammatory cytokine and propose it as a molecular target for the 
management of inflammatory disorders. In a more recent study, downstream signaling 
molecules of CD40 have been targeted for intervention. The family of tumor necrosis 
factor receptor associated factor or TRAFs has shown promise as a viable target. “A 
CD40-TRAF6 blocking peptide has also been reported to inhibit production of TNF-
Alpha, IL-1beta and IL-6 in human monocytes. However, the inhibitory effect of CD40-
TRAF6 blocking peptides on CD40-induced dendritic cell maturation and macrophage 
anti microbial activities support the concern that pharmacological inhibition of CD40-
TRAF6 signaling may cause significant immunosuppression”(Portillo et al, 2014, pg.31). 
In lieu of the problematic CD40-TRAF6, a related protein CD40-TRAF2, 3 has been 
targeted and shows great promise. Inhibiting CD40-TRAF2, 3 may help manage the 
inflammatory response without having a major impact on natural cell mediated immune 
response (Portillo et al, 2014).  
Lastly, Yu et al, 2011 introduces the idea of utilizing biologically occurring SOCS 
or suppressor of cytokine signaling proteins. SOCS proteins are a part of a negative 
feedback loop for cytokines; they regulate the intensity and duration of cytokine 
responses. “SOCS1 negatively regulates the expression of chemokines and other pro-
inflammatory molecules and may contribute to the mechanism that mitigates intraocular 
inflammation by limiting the recruitment of inflammatory cells into the retina” (Yu et al, 
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2011, pg.6984). Finding a novel method of increasing endogenous SOCS1 or introducing 
exogenous SOCS1 may mediate a harmful inflammatory response.  
Inconsistent Findings and Limitations 
All  fourteen vitreous cytokines and growth factors tested in this analysis have 
been shown to play a role in the inflammatory response. As evidenced in the introduction, 
there was enough support for each cytokine to expect significant changes after a cataract 
procedure. As many of the cytokines and growth factors are interconnected, it was 
expected that other factors associated to SCD40L would also come up as significantly 
increased in group 3. IL-6 and IL-8 levels for example have been shown to increase 
following an increase in SCD40L. 
The lack of significant findings in this analysis is not characteristic of the existing 
body of literature on the subject and can be due to a number of reasons. The most obvious 
reason for this discrepancy is a dilution or contamination of the vitreous samples. 
Dilution and contamination may have been caused by the method of vitreous sample 
collection, the timing of the collection or the handling of the sample post collection.  
 The timing of collection is also an issue in the second analysis involving group 
three. Whereas all of the vitreous samples for group two were collected right after the 
cataract procedures, group three does not have this advantage. In group 3, the timing 
between cataract surgery and vitreous collection differ for all of the patients. It would 
have been interesting to analyze the effects of timing on vitreous levels within this group 
however it was not possible due to the limited number of subjects in this group and the 
lack of dates for some of the previous cataract surgeries.  
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The number of subjects in group 3 or the history of cataract group was also a 
limitation in regards to the overall design of the study.  Group 3 contained only six 
patients and thus limited the statistical tests that could be used for analysis. The large 
number of cytokines being tested in addition to the limited number of subjects made it 
difficult to run a combined independent samples t-test for all of the cytokines without 
making an unacceptable type 1 error. The small number of subjects also prevented the 
use of a MANOVA analysis of the cytokines. The use of separate independent samples t-
tests for each cytokine limited the analysis of within group effects and may have hidden 
some significant effects. A larger sample size for group three in addition to more 
consistent vitreous sample collection would lend themselves to a more significant 
analysis of  inflammatory vitreous cytokines and growth factors.  
Summary  
There is an increasing incidence of cataract surgery both worldwide and in the 
United States. The increase in cataract surgery must be met with better prognosis and 
efficacy for cataract procedures. One of the potential complications of cataract surgery is 
the post-cataract inflammatory response. The inflammatory response can trigger other 
post-surgery complications including macular edema and pseudophakic retinal 
detachments.  
This objective of this analysis was to quantify changes in the levels of specific 
vitreous inflammatory cytokines following cataract surgery. The analysis of vitreous 
samples obtained from patients receiving pars plana vitrectomy revealed a significant 
increase in the levels of cytokine SCD40L post cataract surgery. The role of SCD40L in 
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inflammation is regulated by its receptor CD40. CD40 can bind and effect important 
downstream signaling molecules including chemokines and muller cells. The increase of 
SCD40L levels following cataract surgery and its corresponding role in the inflammatory 
response may be used to mediate the post-surgery inflammatory response. Biologically 
controlling SCD40L levels post-surgery can decrease the occurrence of post surgical 
complications in cataract patients. Current and future lines of research in this area involve 
targeting platelet activation, the CD40L receptor, and suppressor of cytokine signaling 
proteins.  
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  8th	  avenue,	  Apt	  7G,	  New	  York,	  NY	  10039	  
Shimul.s.Begum@gmail.com	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  324-­‐0184	  
	  
	  
EDUCATION	  
Boston	  University	  School	  of	  Medicine,	  Division	  of	  Graduate	  Medical	  Sciences	  
Boston,	  MA	  
Masters	  of	  Science	  in	  Medical	  Sciences,	  May	  2015(anticipated)	  
	  
Dartmouth	  College,	  	  
Hanover,	  NH	  	  
Bachelor	  of	  Arts	  in	  Neuroscience,	  June	  2012	  	  
	  
EXPERIENCE	  	  
	  
Beth	  Israel	  Deaconess	  Medical	  Center:	  Ophthalmology	  Clinic	  –	  Boston,	  MA-­‐	  September	  
2014-­‐	  Present	  	  
Master’s	  Thesis	  Student	  	  
Shadow	  physicians	  in	  ophthalmology	  clinic	  and	  act	  as	  physicians	  scribe.	  Assist	  in	  clinical	  
activities	  such	  as	  intravitreal	  injections	  and	  patient	  work	  ups.	  Act	  as	  a	  research	  
collaborator	  and	  spearhead	  an	  independent	  research	  project.	  	  
	  
Boston	  University:	  Residence	  Life-­‐Boston,	  MA-­‐	  August	  2014-­‐Present	  	  
Resident	  Assistant	  	  
Serve	  as	  a	  live	  in	  role	  model,	  advisor	  and	  resource	  for	  Boston	  University	  undergraduate	  
students.	  Assist	  in	  community	  building	  and	  administrative	  tasks	  for	  the	  South	  Campus	  
area.	  	  
	  
Mt.	  Sinai	  Medical	  School:	  Pasinetti	  Lab	  –New	  York,	  NY	  -­‐November	  2012-­‐	  July	  2013	  
Research	  Assistant	  
Perform	  analytical	  techniques	  such	  as	  western	  blotting	  and	  DNA	  gel	  electrophoresis.	  
Assist	  with	  collaborative	  research	  projects.	  	  Published	  in	  two	  subsequent	  papers	  related	  
to	  laboratory	  work.	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Publications	  	  
	  
1)	  IVIG	  immunotherapy	  protects	  against	  synaptic	  dysfunction	  in	  Alzheimer's	  disease	  through	  complement	  
anaphylatoxin	  C5a-­‐mediated	  AMPA-­‐CREB-­‐C/EBP	  signaling	  pathway.	  
	  	  	  	  	  Gong	  B1,	  Pan	  Y,	  Zhao	  W,	  Knable	  L,	  Vempati	  P,	  Begum	  S,	  Ho	  L,	  Wang	  J,	  Yemul	  S,	  Barnum	  S,	  Bilski	  A,	  Gong	  BY,	  	  	  	  	  	  	  
	  	  	  	  	  	  Pasinetti	  GM.	  	  
	  	  	  	  2)	  Epigenetic	  mechanisms	  linking	  diabetes	  and	  synaptic	  impairments	  
	  	  	  	  	  Jun	  Wang1,3Bing	  Gong1,	  Wei	  Zhao1,	  Cheuk	  Tang2,	  Merina	  Varghese1,	  Tuyen	  Nguyen2,	  Weina	  Bi1,	  Amanda	  Bilski1,	  	  	  	  	  	  
	  	  	  	  	  Shimul	  Begum1,	  Prashant	  Vempati1,	  	  Lindsay	  Knable1,	  Lap	  Ho1	  and	  Giulio	  M.	  Pasinetti1,3	  
	  
	  
Taj	  Kebab	  and	  Curry	  –	  New	  York,	  NY-­‐	  June	  2012-­‐	  July	  2013	  	  
Receptionist/	  Waitress	  	  
Responsible	  for	  phone,	  fax	  and	  in	  person	  orders.	  In	  charge	  of	  cash	  register	  and	  
reception.	  Customer	  service	  and	  waitressing	  as	  required.	  
	  
Office	  of	  Pluralism	  and	  Leadership	  -­‐	  Hanover,	  NH-­‐	  September	  2011-­‐	  June	  2012	  
Pan	  Asian	  Council	  Intern	  	  
Organize	  and	  coordinate	  events	  for	  over	  twenty	  Pan	  Asian	  student	  organizations.	  Work	  
closely	  with	  administration,	  faculty	  and	  student	  leaders	  as	  an	  advocate	  for	  structural	  
change	  within	  the	  Pan	  Asian	  Community.	  Maintain	  and	  update	  the	  Asian	  American	  
Alumni	  network.	  Serve	  as	  an	  Asian	  and	  Asian	  American	  peer	  counselor.	  	  
	  
Global	  Kids,	  Inc.	  –	  New	  York,	  NY-­‐	  June	  2011	  –	  August	  2011	  
Intern	  	  
Assisted	  in	  teaching	  a	  global	  warming	  and	  sustainability	  course	  to	  underprivileged	  and	  
underrepresented	  high	  school	  students.	  Worked	  with	  development	  on	  fundraising	  and	  
grants.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Dartmouth	  Psychological	  and	  Brain	  Sciences	  Laboratory	  –	  Hanover,	  NH	  -­‐	  January,	  2011-­‐
June	  2011	  
Research	  Assistant	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Created	  an	  emotions	  task	  that	  tests	  the	  ability	  to	  distinguish	  and	  recognize	  emotions	  in	  
children.	  Conducted	  experiments	  and	  facial	  recognition	  tasks	  on	  children	  from	  ages	  4	  to	  
14	  
	  
New	  York-­‐Presbyterian	  Hospital	  –	  New	  York,	  NY-­‐	  September	  2010-­‐	  December	  2010	  
Anesthesiology	  Intern	  	  	  	  
Assisted	  resident	  anesthesiologist	  with	  placement	  of	  intravenous	  fluid	  and	  other	  pre-­‐
surgery	  preparations	  in	  pediatric	  patients	  aged	  3	  months	  to	  18	  years.	  Prepared	  
anesthesiology	  station	  and	  equipment	  before	  pediatric	  surgeries.	  	  
	  
	  46	  
 
Milan	  (South	  Asian	  student	  association)	  –	  Hanover,	  NH-­‐September	  2010	  –	  June	  2010	  
President	  Social	  
Organized	  and	  managed	  major	  social	  and	  educational	  events	  for	  the	  entire	  student	  
body.	  Oversaw	  an	  executive	  board	  of	  8	  members	  as	  well	  as	  a	  general	  membership	  of	  
over	  30	  people.	  
	  
SERVICE	  	  
Rosie’s	  Place-­‐	  Boston,	  Ma-­‐	  May	  2014-­‐	  present	  
Volunteer	  	  
Assist	  in	  preparing	  and	  serving	  meals	  to	  homeless	  women	  and	  children	  during	  lunch	  and	  
dinner	  periods.	  	  
	  
Morgan	  Stanley	  Children’s	  Hospital-­‐	  New	  York,	  NY-­‐	  September	  2012-­‐	  May	  2013	  	  
Volunteer	  
Provided	  companionship	  for	  pediatric	  patients	  aged	  6	  months	  to	  18	  years.	  Maintained	  
child	  life	  room	  for	  Neurology	  floor	  and	  supervised	  playroom	  hours.	  	  
	  
Dartmouth	  Cancer	  Patient	  Services	  –	  Hanover,	  NH-­‐January	  2011-­‐	  June	  2012	  
Member/Volunteer	  
Made	  Hospital	  visits	  to	  cancer	  patients	  at	  the	  Dartmouth	  Hitchcock	  Medical	  Center.	  
Provided	  services	  that	  patients	  were	  unable	  to	  do	  for	  themselves,	  i.e.	  housework,	  
manual	  chores.	  	  
	  
LANGUAGE	  
Fluent	  in	  Bangla	  
References	  	  -­‐ Merina	  Varghese,	  Post-­‐Doctoral	  Fellow,	  Mt.	  Sinai	  Hospital	  
merina.varghese@mssm.edu	  
	  -­‐ Nora	  Yasumura,	  Office	  of	  Pluralism	  and	  Leadership	  (Dartmouth	  College)	  
nora.yasumura87@gmail.com,	  603-­‐252-­‐5819	  
	  
